• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number UNKNOWN
Device Problem Leak/Splash (1354)
Patient Problem Aortic Regurgitation (1716)
Event Date 10/18/2019
Event Type  Death  
Manufacturer Narrative
Based on the present information there are no device related malfunctions the device dislodgement was resolved and no issues were identified after re-implanting the device.Based on this it is reasonable to attribute the original dislodgement to user error or procedural issues.The manufacturer is reporting an off label action which may have increased the risk to the patient.Per the perceval ifu 850-07ls202.Directions for use: "warning: a removed perceval s prosthesis must not be reimplanted, because its integrity is no longer ensured." at this time the reported off-label action is not suspected to have caused any harm to the patient as the patient death was reportedly not valve related.Because there is no indication of device related malfunctions or inefficiencies at this time the manufacturer is submitting an initial and final report and will not perform any further investigations related to this case.
 
Event Description
On (b)(6) 2019 a patient received an avr, plus 1 graft, after presenting to the hospital with cardiac arrest with low ejection fration (ef) and atrial fibrillation (af).The manufacturer was notified of the following.A perceval s sutureless aortic heart was implanted, all visual checks were completed, no pinwheeling or over-sizing noted.Patient was taken off pump and the site noticed a paravalvular leak.After reopening they noticed the cage was higher and had slightly migrated.The valve was explanted and recollapsed.The site re-positioned the perceval in the annulus.On visual inspection the cage did look lower after second implant.The patient came off pump successfully.It was reported that the following day the patient had a cardiac arrest.They re-operated to inspect, but the patient suffered cardiac arrest and passed away.It was deemed not valve related and most likely due to air.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
MDR Report Key9387733
MDR Text Key168429231
Report Number1718850-2019-01185
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 10/30/2019,11/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/30/2019
Event Location Hospital
Date Report to Manufacturer10/30/2019
Date Manufacturer Received10/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
-
-